|
|
|
|
|
|
|
|
| About Chris Waller (Pfizer, Inc.) |
|
Chris L. Waller, Ph.D. is the Senior Director of Precompetitive Collaborations in Worldwide Technology at Pfizer, Inc., where his interest is in the development of collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs. Waller has a Doctorate in Medicinal Chemistry and Natural Products from the University of North Carolina-Chapel Hill and a Bachelors of Science in Pre-medical Studies from Davidson College.
In his current role, Waller is spearheading a new initiative within Pfizer that consists of three primary elements: (1) the definition and promotion of industry standards (e.g., data models, APIs, processes, etc.) across the Research and Development and Medical continuum through participation on various cross-pharmaceutical company entities (e.g., Waller is a Senior Core Member of the Pistoia Alliance, Inc.); (2) proactive pursuit of pre/non-competitive collaborative application or technology development opportunities (e.g., industry partnerships focused on the development of commodity applications or services); and (3) identification and cultivation of opportunities to generate revenue by monetizing Pfizer’s portfolio of products and services (e.g., divestment and/or licensing of Pfizer-developed applications).
He was previously Worldwide Head of Chemistry Informatics at Pfizer where he was responsible for the strategic direction of the IT portfolio of products and services in support of enterprise chemical and biological data access and analysis as well as medicinal chemistry compound design and synthesis. Prior to joining Pfizer, Waller held various positions at Eli Lilly and Company (Sphinx Laboratories), OSI Pharmaceuticals, Inc. and the U.S. Environmental Protection Agency.
|
|
The Pistoia Alliance, Inc. – A Construct for Precompetitive Collaboration
Chris L. Waller, Ph.D. (Pfizer, Inc.)
An Open Source initiative (http://pistoiaalliance.org) has been established to provide the foundation of data standards, ontologies and associated web-services to enable the Pharmaceutical discovery workflow through common business terms, relationships and processes. Initial focus has been on chemistry, biological screening and sample logistics. Every pharma company and software vendor is challenged by the technical inter-conversion, collation and interpretation of drug/agrochemical discovery data and as such, there is a vast amount of duplication, conversion and testing that could be reduced if a common foundation of data standards, ontologies and web-services could be promoted and ideally agreed within a non-proprietary and non-competitive framework. This would allow interoperability between a traditionally diverse set of technologies to benefit the healthcare sector. Current progress, learnings and how companies, academics and others can participate in this approach will be described.
|
|
|
|
|
|
|
|
|
|
|
